Our research interest is to understand the early events involved in the host response to viruses, with the long-term objective to utilize the knowledge of the host response against viral infection to develop novel therapeutic approaches for the treatment of resistant cancers. We have a particular interest in viruses that can be used as treatments against cancer cells called oncolytic viruses. We aim to provide new basic knowledge on restrictive/facilitating pathways to oncolytic virus infection in cancer cells. Such work may lead to the translational development and the engineering of novel oncovirotherapeutic approaches directed towards the fight of cancer.

Our laboratory is composed of between 10-12 people at all educational levels and career stages. We have a highly international laboratory with students and postdocs from a wide range of countries.